SoftBank-Backed Relay Therapeutics Seeks $265 Million in IPO

Bookmark
(Bloomberg) -- Oncology drug developer Relay Therapeutics Inc. set terms for a U.S. initial public offering that could raise as much as $265 million.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.